• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Sterilization Equipment Market to Reach $23.73 Billion by 2027 With COVID-19 Impact, at a CAGR of 12.2% from 2020 - Meticulous Research® Analysis

    12/1/20 4:34:34 AM ET
    $STE
    $CMD
    $MMM
    $SVA
    Industrial Specialties
    Health Care
    Medical/Dental Instruments
    Health Care
    Get the next $STE alert in real time by email

    London, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Meticulous Research®, in its latest publication, titled “Sterilization Equipment Market by Product & Services {Equipment [Heat, Low-temperature (Ozone, Formaldehyde), Filtration), Consumables (Sterilization Indicators, Sterilants), Services (Gamma, Steam)], End User (Hospitals, Pharma)} - Global Forecast to 2027”, states that the sterilization equipment market is expected to grow at a CAGR of 12.2% from 2020 to 2027 to reach $23.73 billion by 2027.

    Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5141

    The growth of the sterilization equipment market is mainly attributed to the growing incidences of hospital-acquired infections, impact of the COVID-19 pandemic, rising number of surgical procedures, rising demand for sterilization in the food food-borne diseases, and increasing sterilization demand from pharmaceutical and biotechnology industries. However, the harmful effects of ethylene oxide and concerns regarding the safety of reprocessed instruments restrict the market's growth to some extent.

    Sterilization equipment are one of the core parts of any healthcare facility. The current COVID-19 pandemic has changed the way markets function at both the demand and supply side. Moreover, increasing demand for vaccines supported the growth of the market. For instance:

    • As per the data from Fierce Pharma, in April 2020, Sinovac Biotech Ltd. (China), one of many drugmakers seeking a COVID-19 vaccine, was leveraging China's aid to help it cross the finish line. For this, the company needs to build out a massive new facility on the government's dime. Hence, the company plans to build vaccine production facilities on 230,000 square feet of land to help speed the development of 100 million COVID-19 shots per year.

      Wish to customize this report or get any additional specific information of your interest? Let us know here- https://www.meticulousresearch.com/custom-research.php
    • In March 2020, CanSino Biologics Inc. (China) received regulatory approval to conduct a Phase I trial of its recombinant novel coronavirus vaccine (adenovirus type 5 vector) candidate. Moreover, the state-owned Wuhan Institute of Biological Products also received government approval to move ahead with trials.

    Such initiatives create opportunities for local players of each country to gear up their manufacturing capacity and cater to the rising demand for the various types of sterilization equipment.

    To provide efficient analysis, Meticulous Research® has segmented this market by product (equipment, consumables & accessories, services), end user (hospitals & clinics, medical device companies, pharmaceutical companies, food & beverage industry, and others), and geography (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa).

     Quick Buy - Sterilization Equipment Market Research Report: https://www.meticulousresearch.com/buy_now.php?pformat=445&vformat=1322

    Geographically, North America is projected to command the largest share of the overall sterilization equipment market in 2020, closely followed by Europe and Asia-Pacific. However, Asia-Pacific countries, namely, China and India, are slated to register the highest growth during the forecast period primarily due to the recent outbreak of COVID-19 and various government initiatives to boost sterilization equipment production.

    Based on end user, the hospitals & clinics segment is projected to dominate the overall sterilization equipment market due to the rising hospitalization rate with growing COVID-19 cases, increasing HAIs among healthcare facilities, and the need to maintain a sterile environment for quality care.

    The key players operating in the global sterilization equipment market are STERIS plc. (U.S.), Cantel Medical Corp. (U.S.), Getinge AB (Sweden), 3M Company (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), MATACHANA group (Spain), Cardinal Health, Inc. (U.S.), Sotera Health (U.S.), and Belimed (Switzerland), among others.

    To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/sterilization-equipment-market-5141/

    Scope of the Report:

    Sterilization Equipment Market, by Product

    • Equipment
      • Heat Sterilization Equipment
        • Moist Heat Sterilizers
        • Dry Heat Sterilizers
      • Low-temperature Sterilization Equipment
        • Hydrogen Peroxide / Gas Plasma Sterilization
        • Ethylene Oxide Sterilizers
        • Ozone-based Medical Sterilizers
        • Formaldehyde Sterilizers
        • Others
      • Radiation Sterilization Equipment
      • Filtration Sterilization Equipment
    • Consumables & Accessories
      • Sterilization Indicators
        • Biological Indicators
        • Chemical Indicators
      • Sterilants
      • Instrument Packaging & Pouches
      • Others
    • Services
      • Ethylene Oxide Sterilization Services
      • Gamma Sterilization Services
      • E-beam Sterilization Services
      • Steam Sterilization Services
      • Other Sterilization Services

    Sterilization Equipment Market, by End User

    • Hospitals & Clinics
    • Medical Device Companies
    • Pharmaceutical Companies
    • Food & Beverage Industry
    • Other End Users

    Sterilization Equipment Market, by Geography

    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • France
      • U.K.
      • Italy
      • Spain
      • Rest of Europe (RoE)
    • Asia-Pacific (APAC)
      • Japan
      • China
      • India
      • Rest of APAC (RoAPAC)
    • Latin America
    • Middle East & Africa

    Download Free Sample Report Now @ https://www.meticulousresearch.com/download-sample-report/cp_id=5141

    Amidst this crisis, Meticulous Research® is continuously assessing the impact of COVID-19 pandemic on various sub-markets and enables global organizations to strategize for the post-COVID-19 world and sustain their growth. Let us know if you would like to assess the impact of COVID-19 on any industry here- https://www.meticulousresearch.com/custom-research.php

    Related Reports:

    Infection Control Market by Product [Sterilization (Steam, Radiation, Sterilant, Indicators), Disinfection (Washer, UV Disinfection, Disinfectants), Endoscope Reprocessing, Protective Barriers], and End User - Global Forecast to 2027

    https://www.meticulousresearch.com/product/infection-control-market-5058/

    Medical/Hospital Beds Market by Product (Bed, Accessories), Technology (Power, Manual), Type of Care (Curative, Rehabilitation), Healthcare Facilities (Critical, Bariatric, Long-term, Paediatric, Maternal, Home Care) - Global Forecast to 2027

    https://www.meticulousresearch.com/product/hospital-beds-market-5091/

    Infectious Disease Diagnostics Market by Product and Solution (Consumables, System, Software and Services), Technology (Immunodiagnostics, PCR, INAAT), Disease (HIV, HAIS, Influenza), End User (Hospital, Reference Lab, Research) - Global Forecast to 2027

    https://www.meticulousresearch.com/product/infectious-disease-diagnostics-market-4976/

    About Meticulous Research®

    Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

    The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details. With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.

    Contact:
    Mr. Khushal Bombe
    Meticulous Research®
    Direct Lines: +1-646-781-8004 (North America)
    +44-203-868-8738 (Europe)
    +91 744-7780008 (Asia-Pacific)
    Email- [email protected]
    Visit Our Website: https://www.meticulousresearch.com/
    Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
    Content Source: https://www.meticulousresearch.com/press-release/sterilization-equipment-market-2027/508 

     
    Get the next $STE alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STE
    $CMD
    $MMM
    $SVA

    CompanyDatePrice TargetRatingAnalyst
    3M Company
    $MMM
    1/16/2026$182.00Overweight → Neutral
    Analyst
    Cardinal Health Inc.
    $CAH
    1/9/2026Neutral → Buy
    Citigroup
    Cardinal Health Inc.
    $CAH
    12/9/2025$243.00Overweight
    Barclays
    3M Company
    $MMM
    12/8/2025$178.00Buy → Hold
    Deutsche Bank
    3M Company
    $MMM
    10/22/2025$160.00Underweight → Equal-Weight
    Morgan Stanley
    STERIS plc (Ireland)
    $STE
    7/15/2025$276.00Equal-Weight → Overweight
    Morgan Stanley
    Cardinal Health Inc.
    $CAH
    6/3/2025$179.00Equal Weight → Overweight
    Wells Fargo
    STERIS plc (Ireland)
    $STE
    5/29/2025$263.00Hold
    Jefferies
    More analyst ratings

    $STE
    $CMD
    $MMM
    $SVA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Alt Aaron E covered exercise/tax liability with 1,914 shares and sold $524,964 worth of shares (2,328 units at $225.50), decreasing direct ownership by 14% to 26,408 units (SEC Form 4)

    4 - CARDINAL HEALTH INC (0000721371) (Issuer)

    2/18/26 4:25:35 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Amendment: EVP, Chief Legal Off & Secret Rhodes Kevin H covered exercise/tax liability with 5,837 shares, decreasing direct ownership by 15% to 32,633 units (SEC Form 4)

    4/A - 3M CO (0000066740) (Issuer)

    2/18/26 4:14:11 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Amendment: EVP & Chief Info Digital Off Murphy Mark W. covered exercise/tax liability with 4,793 shares, decreasing direct ownership by 27% to 13,025 units (SEC Form 4)

    4/A - 3M CO (0000066740) (Issuer)

    2/18/26 4:12:20 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $STE
    $CMD
    $MMM
    $SVA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cardinal Health report highlights cost savings and provider confidence in biosimilars

    New analysis shows biosimilars are projected to strengthen cost savings and provider confidence across the healthcare ecosystem, with oncology leading in adoption and accessibility gains.DUBLIN, Ohio, Feb. 24, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today released its 2026 Biosimilars Report: Driving access and patient outcomes in physician practices, which highlights the substantial savings biosimilars have delivered to the U.S. healthcare system and the strong confidence providers have in these treatments. "Since 2015, biosimilars have generated more than $56 billion i

    2/24/26 7:00:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    3M appoints Meagan Linn as Senior Vice President, Government Affairs

    ST. PAUL, Minn., Feb. 16, 2026 /PRNewswire/ -- 3M today announced the appointment of Meagan Linn as Senior Vice President, Government Affairs. In this role, Linn will oversee the company's engagement with the executive branch, policymakers, regulatory agencies, and industry associations, globally to advance public policy dialogue. She will also be responsible for developing business growth through government contracts. Linn brings 20 years of experience in public policy, with 12 years at Northrop Grumman Corporation, most recently as government policy lead and Chief of Staff, an

    2/16/26 10:00:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc

    2/12/26 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $STE
    $CMD
    $MMM
    $SVA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    January 22, 2021 - Coronavirus (COVID-19) Update: January 22, 2021

    For Immediate Release: January 22, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. The criminal investigation found th

    1/22/21 3:54:10 PM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $STE
    $CMD
    $MMM
    $SVA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    3M downgraded by Analyst with a new price target

    Analyst downgraded 3M from Overweight to Neutral and set a new price target of $182.00

    1/16/26 8:27:24 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    Cardinal Health upgraded by Citigroup

    Citigroup upgraded Cardinal Health from Neutral to Buy

    1/9/26 8:24:26 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Barclays initiated coverage on Cardinal Health with a new price target

    Barclays initiated coverage of Cardinal Health with a rating of Overweight and set a new price target of $243.00

    12/9/25 8:43:24 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    $STE
    $CMD
    $MMM
    $SVA
    SEC Filings

    View All

    SEC Form 10-Q filed by STERIS plc (Ireland)

    10-Q - STERIS plc (0001757898) (Filer)

    2/6/26 4:04:07 PM ET
    $STE
    Industrial Specialties
    Health Care

    SEC Form 10-Q filed by Cardinal Health Inc.

    10-Q - CARDINAL HEALTH INC (0000721371) (Filer)

    2/5/26 8:47:09 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    3M Company filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - 3M CO (0000066740) (Filer)

    2/5/26 8:32:39 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    $STE
    $CMD
    $MMM
    $SVA
    Leadership Updates

    Live Leadership Updates

    View All

    3M appoints Meagan Linn as Senior Vice President, Government Affairs

    ST. PAUL, Minn., Feb. 16, 2026 /PRNewswire/ -- 3M today announced the appointment of Meagan Linn as Senior Vice President, Government Affairs. In this role, Linn will oversee the company's engagement with the executive branch, policymakers, regulatory agencies, and industry associations, globally to advance public policy dialogue. She will also be responsible for developing business growth through government contracts. Linn brings 20 years of experience in public policy, with 12 years at Northrop Grumman Corporation, most recently as government policy lead and Chief of Staff, an

    2/16/26 10:00:00 AM ET
    $MMM
    Medical/Dental Instruments
    Health Care

    METTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors

    Mettler-Toledo International Inc. (NYSE:MTD) announced today that Michael J. Tokich has been appointed to its Board of Directors, effective February 5, 2026. Mr. Tokich served for over 17 years as Senior Vice President and Chief Financial Officer ("CFO") at STERIS plc (NYSE:STE), a leading global healthcare and life science provider of products and services, prior to recently transitioning to the role of Senior Financial Advisor at STERIS. Mr. Tokich joined STERIS in 2000 and held various senior financial roles prior to his appointment as CFO in 2008. Roland Diggelmann, Chair of the Board, stated, "Mike is a highly accomplished executive who brings nearly two decades of U.S. public comp

    1/20/26 4:30:00 PM ET
    $MTD
    $STE
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Industrial Specialties
    Health Care

    CooperCompanies Appoints Walter M Rosebrough, Jr. to its Board of Directors

    SAN RAMON, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- CooperCompanies (NASDAQ:COO), a leading medical device company, announced today that the Company's Board of Directors (the "Board") has appointed Walter (Walt) M Rosebrough, Jr. as an independent director, effective as of January 3, 2026. In connection with this appointment, the Company also has entered into a cooperation agreement (the "Cooperation Agreement") with Browning West, LP. ("Browning West"). Mr. Rosebrough will join the Board's Corporate Governance & Nominating Committee. The Board has also agreed that, by the end of 2026, it shall provide due and serious consideration for Mr. Rosebrough to be appointed Chair of the Board. In

    12/23/25 8:00:00 AM ET
    $COO
    $STE
    $VREX
    Ophthalmic Goods
    Health Care
    Industrial Specialties
    Industrial Machinery/Components

    $STE
    $CMD
    $MMM
    $SVA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Sinovac Biotech, Ltd.

    SC 13D/A - SINOVAC BIOTECH LTD (0001084201) (Subject)

    9/12/24 4:03:46 PM ET
    $SVA
    Major Pharmaceuticals
    Health Care

    Amendment: SEC Form SC 13D/A filed by Sinovac Biotech, Ltd.

    SC 13D/A - SINOVAC BIOTECH LTD (0001084201) (Subject)

    6/17/24 4:02:44 PM ET
    $SVA
    Major Pharmaceuticals
    Health Care

    SEC Form SC 13G/A filed by Sinovac Biotech, Ltd. (Amendment)

    SC 13G/A - SINOVAC BIOTECH LTD (0001084201) (Subject)

    3/20/24 7:33:23 AM ET
    $SVA
    Major Pharmaceuticals
    Health Care

    $STE
    $CMD
    $MMM
    $SVA
    Financials

    Live finance-specific insights

    View All

    Cardinal Health Board of Directors Approves Quarterly Dividend

    DUBLIN, Ohio, Feb. 12, 2026 /PRNewswire/ -- Cardinal Health (NYSE:CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5107 per share, out of the Company's capital surplus. The dividend will be payable on April 15, 2026 to shareholders of record at the close of business on April 1, 2026. About Cardinal HealthCardinal Health is a distributor of pharmaceuticals and specialty products; a global manufacturer and distributor of medical and laboratory products; a supplier of home-health and direct-to-patient products and services; an operator of nuc

    2/12/26 4:45:00 PM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    Cardinal Health Reports Second Quarter Fiscal Year 2026 Results and Raises Outlook

    Revenue increased 19% to $65.6 billionGAAP1 operating earnings increased 29% to $707 million; GAAP diluted EPS increased 19% to $1.97Non-GAAP operating earnings increased 38% to $877 million; non-GAAP diluted EPS increased 36% to $2.63Cardinal Health raises fiscal year 2026 non-GAAP EPS guidance2 to $10.15 to $10.35Cardinal Health completes annual baseline share repurchase of $750 millionCardinal Health reaches targeted leverage range3DUBLIN, Ohio, Feb. 5, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today reported second quarter fiscal year 2026 revenues of $65.6 billion, an increase of 19% from the second quarter of fiscal year 2025. Second quarter GAAP operating earnings increased 29%

    2/5/26 6:45:00 AM ET
    $CAH
    Other Pharmaceuticals
    Health Care

    STERIS Announces Financial Results for Fiscal 2026 Third Quarter

    Total revenue from continuing operations increased 9%; constant currency organic revenue grew 8% As reported EPS from continuing operations increased to $1.96; adjusted EPS increased to $2.53Fiscal 2026 outlook maintained DUBLIN, IRELAND, Feb. 04, 2026 (GLOBE NEWSWIRE) -- STERIS plc (NYSE:STE) ("STERIS" or the "Company") today announced financial results for its fiscal 2026 third quarter ended December 31, 2025. Total revenue from continuing operations for the third quarter of fiscal 2026 increased 9% to $1.5 billion compared with $1.4 billion in the third quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations for the third quarter was 8%. "We are pl

    2/4/26 4:30:00 PM ET
    $STE
    Industrial Specialties
    Health Care